Burns Matteson Capital Management, LLC Verona Pharma PLC Transaction History
Burns Matteson Capital Management, LLC
- $186 Billion
- Q1 2025
A detailed history of Burns Matteson Capital Management, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Burns Matteson Capital Management, LLC holds 3,605 shares of VRNA stock, worth $264,787. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,605Holding current value
$264,787% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
232Shares Held
68.6MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$470 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$410 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$249 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$230 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$230 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.48B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...